Mark B. van der Waal

Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective

Mark B. van der Waal, J. Flach, Pamela D. Browne et al. · PharmaNutrition · 2018 · 33 citations · Full text

Life Sciences, Pharmacotherapy, Gastrointestinal Pharmacotherapy +14

Blockchain-facilitated sharing to advance outbreak R&D

Mark B. van der Waal, Carolina dos S. Ribeiro, Moses Ma et al. · Science · 2020 · 25 citations · Full text

Management, Infectious Disease Control, Supply Chain Management +13

Accelerating microbiota product development: The Societal Impact Value Cycle as a conceptual model to shape and improve public-private valorization processes

Linda van de Burgwal, Mark B. van der Waal, Eric Claassen · PharmaNutrition · 2018 · 24 citations · Full text

Life Sciences, Biotechnology, Microbiology +12

Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model

Linda van de Burgwal, Carolina dos S. Ribeiro, Mark B. van der Waal et al. · Vaccine · 2018 · 23 citations · Full text

Veterinary Medicine, Innovation Management, Innovation +9

Medical doctors’ perceptions on probiotics: Lack of efficacy data hampers innovation

J. Flach, António Dias, S.H.M. Rademaker et al. · PharmaNutrition · 2017 · 22 citations · Full text

Life Sciences, Health Sciences, Clinical Medicine +9